On December 1, Gelonghui reported that hubei jumpcan pharmaceutical (600566.SH) announced that according to the notice issued by the National Medical Insurance Administration and the Ministry of Human Resources and Social Security regarding the 'National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalogue (2024)', the products of its wholly-owned subsidiary, hubei jumpcan pharmaceutical group co., ltd., namely pediatric chichiao clearing heat syrup and fexofenadine hydrochloride dry suspension, have been included in the 'National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalogue (2024)' (hereinafter referred to as the 'National Medical Insurance Catalogue') for the first time through negotiations.
济川药业(600566.SH)子公司产品小儿豉翘清热糖浆以及盐酸非索非那定干混悬剂进入国家医保目录
hubei jumpcan pharmaceutical (600566.SH) subsidiary products Children's Chiqiao Qingre Syrup and Fexofenadine Hydrochloride Dry Suspension have been included in the national medical insurance catalog.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated